Creative Planning Astria Therapeutics, Inc. Transaction History
Creative Planning
- $103 Billion
- Q4 2024
A detailed history of Creative Planning transactions in Astria Therapeutics, Inc. stock. As of the latest transaction made, Creative Planning holds 97 shares of ATXS stock, worth $619. This represents 0.0% of its overall portfolio holdings.
Number of Shares
97Holding current value
$619% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ATXS
# of Institutions
115Shares Held
50.3MCall Options Held
75KPut Options Held
6.2K-
Perceptive Advisors LLC New York, NY6.49MShares$41.4 Million1.91% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.11MShares$32.6 Million0.73% of portfolio
-
Vestal Point Capital, LP New York, NY4.18MShares$26.7 Million2.22% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA3.55MShares$22.7 Million6.29% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$22.5 Million0.0% of portfolio
About Astria Therapeutics, Inc.
- Ticker ATXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,178,000
- Market Cap $97M
- Description
- Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage...